Female leadership in healthcare in Boston, Massachusetts

Rachel Sisodia is a renowned doctor specializing in Gynecologic Oncology, located in Boston, Massachusetts, United States. At the forefront of medicine, the institution fosters a culture of collaboration, pushes the boundaries of medical research, and educates the brightest medical minds. Dr. Sisodia is committed to providing expert care safely and effectively, with a focus on performing complex surgeries and administering oncologic treatments for various gynecologic cancers. As the Chief Quality Officer for Mass General Brigham, she ensures the quality and safety of healthcare provided across the system. Dr. Sisodia's research interests include patient reported outcomes, perioperative care redesign, and improving surgical outcomes for women with gynecologic malignancies. The institution offers secure online access to health information, accepts various insurance plans, and is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll. Dr. Sisodia's dedication to providing world-class care and promoting female leadership in healthcare make her a valuable asset to the institution.

Welcome to Landmark Bio, your premier partner in advancing cutting-edge therapies from concept to clinic. Located at 300 North Beacon Street, Watertown, Massachusetts, we specialize in transforming today's pioneering research into tomorrow's life-changing therapies. Whether you're an academic researcher, a physician scientist, a startup innovator, or a technical operations executive, Landmark Bio is here to help you navigate the complex journey of drug development with unmatched expertise and state-of-the-art facilities. Our comprehensive services go beyond manufacturing cell and gene therapies, genome editing, and mRNA products. We offer a full spectrum of capabilities, including translational research, process and analytical development, GMP manufacturing, quality control, and regulatory CMC support. Our holistic approach ensures that we provide the necessary guidance and solutions to bring your projects from discovery through to commercialization.